FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/08/2026
Voltar para busca
Dado oficial do USPTO
BICYCLE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
03/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
21/05/2024
Data de registro
27/01/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/01/2026
Última transação
03/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
GB
Examinador
BERGER, MAGDALENA
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Bicycletx Limited
Representantes
CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productspharmaceutical preparations for use in oncology for both solid and liquid tumoursmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disorders; pharmaceutical preparations for use as diagnosticsdiagnostic preparations for medical use; pharmaceutical preparations for use as clinical imaging agents for positron emission tomography use
Classe 42
Scientific research; scientific study and research in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; laboratory research services in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; providing informationconsultancy and advisory services relating to the designplanning and implementation of scientific and clinical research for others
Classe 44
Medical services; medical testing for diagnostic or treatment purposes; healthcare services; pharmaceutical servicespharmaceutical compounding services; medical consulting services; advisory services relating to pharmaceuticalspharmaceutical consultation and providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; consultancy and information services relating to pharmaceuticalspharmaceutical consultation and providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical compounding services in the field of oncology; pharmaceutical compounding services in the field of ophthalmology; pharmaceutical compounding services in the field of neurology; pharmaceutical compounding services in the field of anti-infectives; pharmaceutical compounding services in connection with respiratory disease; pharmaceutical compounding services in connection with cardiovascular disease; pharmaceutical compounding services in connection with metabolic disease; pharmaceutical compounding services in connection with the treatment and/or prevention of viral infections; pharmaceutical compounding services in connection with diagnostics and imaging; pharmaceutical compounding services in connection with renal disease; pharmaceutical compounding services in connection with gastrointestinal disease; pharmaceutical compounding services in connection with muscular skeletal disease; informationconsultancy and advisory services relating to the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
FIMP
FINAL DISPOSITION PROCESSED
03/08/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/04/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/03/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/03/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
27/01/2026
TMBN
TTAB RELEASE CASE TO TRADEMARKS
02/01/2026
OP.T
OPPOSITION TERMINATED NO. 999999
02/01/2026
OP.D
OPPOSITION DISMISSED NO. 999999
02/01/2026
RFNT
REFUSAL PROCESSED BY IB
08/08/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
21/07/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
21/07/2025
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
17/07/2025
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
17/07/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
14/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/03/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/03/2025
PUBO
PUBLISHED FOR OPPOSITION
18/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/02/2025
RFNT
REFUSAL PROCESSED BY IB
29/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/12/2024
RFRR
REFUSAL PROCESSED BY MPU
10/12/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/11/2024
CNRT
NON-FINAL ACTION WRITTEN
25/11/2024
DOCK
ASSIGNED TO EXAMINER
16/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
15/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/10/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
15/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/10/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BICYCLE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.